LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in LENZ Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 63
- 0 vs. Q2 2022
- Shares held
- 29.6M
- −576.2K (−1.9%) vs. Q2 2022
- Total value
- $93.9M
- +$10.9M (+13.1%) vs. Q2 2022
- New holders
- 14
- 17 more added
- Sold out
- 14
- 16 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of Wyoming | 50 | $0 | 0.00% | +50 | New |
| American Portfolios Advisors | 20 | $63 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 200 | $634 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 312 | $989 | 0.00% | +312 | New |
| Daiwa Securities Group Inc. | 169 | $1.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 546 | $2.00K | 0.00% | +546 | New |
| Citigroup Inc | 797 | $3.00K | 0.00% | −3,438−81.2% | Reduced |
| UBS Group AG | 1,526 | $5.00K | 0.00% | −46,696−96.8% | Reduced |
| Quantbot Technologies LP | 1,600 | $5.00K | 0.00% | +1,600 | New |
| Advisor Group Holdings, Inc. | 3,070 | $10.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,548 | $12.0K | 0.00% | +84+2.4% | Added |
| JPMorgan Chase & Co | 6,270 | $20.0K | 0.00% | +1,222+24.2% | Added |
| Tower Research Capital LLC (TRC) | 6,481 | $21.0K | 0.00% | +5,765+805.2% | Added |
| LMR Partners LLP | 10,530 | $33.0K | 0.00% | 00.0% | Unchanged |
| Jump Financial, LLC | 10,800 | $34.0K | 0.00% | −45,117−80.7% | Reduced |
| Dimensional Fund Advisors LP | 10,652 | $34.0K | 0.00% | +10,652 | New |
| Erste Asset Management GmbH | 11,900 | $36.5K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 11,542 | $37.0K | 0.00% | +11,542 | New |
| ExodusPoint Capital Management, LP | 12,836 | $41.0K | 0.00% | +12,836 | New |
| Cannell Capital LLC | 14,308 | $45.0K | 0.01% | +10,356+262.0% | Added |
| Cubist Systematic Strategies, LLC | 15,573 | $49.0K | 0.00% | −53,416−77.4% | Reduced |
| Charles Schwab Investment Management Inc | 17,740 | $57.0K | 0.00% | +17,740 | New |
| Qube Research & Technologies Ltd | 19,993 | $63.0K | 0.00% | +2,350+13.3% | Added |
| Occudo Quantitative Strategies LP | 23,478 | $74.0K | 0.01% | −27,760−54.2% | Reduced |
| Schonfeld Strategic Advisors LLC | 23,600 | $75.0K | 0.00% | −20,900−47.0% | Reduced |
| New York Life Investments Alternatives | 25,333 | $80.0K | 0.08% | +25,333 | New |
| D. E. Shaw & Co., Inc. | 30,284 | $96.0K | 0.00% | −16,765−35.6% | Reduced |
| Bailard, Inc. | 31,300 | $99.0K | 0.00% | +31,300 | New |
| Morgan Stanley | 31,323 | $100.0K | 0.00% | −689,121−95.7% | Reduced |
| Prelude Capital Management, LLC | 32,899 | $104.0K | 0.01% | +8,442+34.5% | Added |
| Simplex Trading, LLC | 38,137 | $120.0K | 0.00% | −30,952−44.8% | Reduced |
| Bank of America Corp | 37,746 | $120.0K | 0.00% | +876+2.4% | Added |
| Man Group plc | 39,225 | $124.0K | 0.00% | +39,225 | New |
| State Street Corp | 47,451 | $150.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 63,094 | $200.0K | 0.00% | +14,531+29.9% | Added |
| Cornercap Investment Counsel Inc | 66,427 | $211.0K | 0.04% | +66,427 | New |
| Bridgeway Capital Management, LLC | 113,500 | $360.0K | 0.01% | +113,500 | New |
| Gsa Capital Partners LLP | 190,703 | $605.0K | 0.08% | +88,352+86.3% | Added |
| Cormorant Asset Management, LP | 199,547 | $633.0K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 219,870 | $696.0K | 0.00% | +61,885+39.2% | Added |
| Goldman Sachs Group Inc | 251,734 | $798.0K | 0.00% | −166,347−39.8% | Reduced |
| Oasis Management Co Ltd. | 255,102 | $809.0K | 0.14% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 260,328 | $825.0K | 0.00% | −176,937−40.5% | Reduced |
| Two Sigma Advisers, LP | 266,400 | $844.0K | 0.00% | +26,700+11.1% | Added |
| Millennium Management LLC | 350,669 | $1.11M | 0.00% | −175,581−33.4% | Reduced |
| Prosight Management, LP | 356,445 | $1.13M | 0.62% | +356,445 | New |
| OUP Management Co., LLC | 406,308 | $1.29M | 2.01% | 00.0% | Unchanged |
| BlackRock Inc. | 482,967 | $1.53M | 0.00% | −5,041−1.0% | Reduced |
| Renaissance Technologies LLC | 521,969 | $1.66M | 0.00% | −265,331−33.7% | Reduced |
| Privium Fund Management (UK) Ltd | 564,946 | $1.79M | 2.29% | +220,379+64.0% | Added |
| Laurion Capital Management LP | 573,600 | $1.82M | 0.05% | 00.0% | Unchanged |
| Opaleye Management Inc. | 577,250 | $1.83M | 0.76% | +117,250+25.5% | Added |
| Artal Group S.A. | 700,000 | $2.22M | 0.12% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 703,071 | $2.23M | 0.14% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 848,412 | $2.69M | 0.05% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 1,057,983 | $3.35M | 0.01% | +1,675+0.2% | Added |
| Tang Capital Management LLC | 1,100,000 | $3.49M | 0.43% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,200,282 | $3.81M | 0.00% | +136,371+12.8% | Added |
| Citadel Advisors LLC | 1,274,047 | $4.04M | 0.01% | −45,789−3.5% | Reduced |
| Avidity Partners Management LP | 1,575,000 | $4.99M | 0.11% | +865,000+121.8% | Added |
| EcoR1 Capital, LLC | 1,582,135 | $5.01M | 0.15% | +419,956+36.1% | Added |
| FMR LLC | 4,872,758 | $15.4M | 0.00% | −354,702−6.8% | Reduced |
| Samsara BioCapital, LLC | 8,459,314 | $26.8M | 6.26% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −401,675−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −300,031−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −131,000−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −87,082−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −50,648−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −14,045−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −13,700−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,749−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,573−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −290−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −141−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |